This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
▼
Saturday, November 8, 2014
Fight For Your Liver: Investment Commentary/ Why investors will be following the liver meeting
Investment Commentary
Meg Tirrell tells us which biotech companies investors will be watching ahead of an annual liver disease conference.
No comments:
Post a Comment